About Diagnovus
Diagnovus is a company based in Nashville (United States) founded in 2011 was acquired by Aegis Science in January 2015.. Diagnovus operates in a competitive market with competitors including InDex Pharmaceuticals, C3J Therapeutics, Genedrive, Combinati and Qantgene, among others.
- Headquarter Nashville, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Aegis Science
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Aegis Science
(Jan 06, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Diagnovus
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2011 | Amount | Seed - Diagnovus | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Diagnovus
Diagnovus has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Aegis Science and TriStar Health Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Drug testing and clinical laboratory services are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Diagnovus
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Diagnovus
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Diagnovus Comparisons
Competitors of Diagnovus
Diagnovus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as InDex Pharmaceuticals, C3J Therapeutics, Genedrive, Combinati and Qantgene, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
DNA-based immunomodulatory drugs for ulcerative colitis are developed.
|
|
| domain | founded_year | HQ Location |
Pathogen-specific antimicrobials are developed for microbial dysbiosis diseases.
|
|
| domain | founded_year | HQ Location |
Provider of point of care molecular diagnostics platform for genotyping and sequence analysis
|
|
| domain | founded_year | HQ Location |
Integrated digital PCR platform with microfluidic consumables is developed.
|
|
| domain | founded_year | HQ Location |
Cancer screening blood tests are offered for early disease detection.
|
|
| domain | founded_year | HQ Location |
PCR-based Human and Animal testing for vector-borne diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Diagnovus
When was Diagnovus founded?
Diagnovus was founded in 2011.
Where is Diagnovus located?
Diagnovus is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
What does Diagnovus do?
Diagnovus was founded in 2011 and based in Nashville, United States. Molecular diagnostics for rare diseases were developed and offered by the company in the healthcare sector. Operations focused on three market products: a PCR-based test assessing Barretts esophageal cancer risk, a gene expression test for eosinophilic esophagitis, and a pharmacogenetic test using buccal swabs. The company was acquired by Aegis Sciences.
Who are the top competitors of Diagnovus?
Diagnovus's top competitors include C3J Therapeutics, InDex Pharmaceuticals and Genedrive.
Who are Diagnovus's investors?
Diagnovus has 2 investors. Key investors include Aegis Science, and TriStar Health Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.